Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Publicado el 29 de abril de 2015 · Inicio del retiro: 14 de noviembre de 2014
Resumen
FDA registra el retiro D-517-2015 de medicamentos de Clase II, publicado el 29 de abril de 2015 e iniciado el 14 de noviembre de 2014. Empresa responsable: Attix Pharmaceuticals; Estado: Finalizado; Cantidad reportada: 1000 grams; Lote: All lots repackaged and distributed between 01/05/12 to 02/12/15. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Attix Pharmaceuticals
- Distribuidor
- Nationwide to compounding pharmacies and research organizations.
- Lote
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Clasificación de riesgo
- Class II
- Área (FDA)
- drug
- País
- Canada
Retiros relacionados
- FDAMethyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in29 de abril de 2015
- FDAHomatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums,29 de abril de 2015
- FDAMethyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix29 de abril de 2015
- FDAPancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix29 de abril de 2015
- FDAAminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix29 de abril de 2015
- FDAAmlodipine besylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix29 de abril de 2015
Preguntas sobre este retiro
¿Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada fue retirado del mercado?
Sí. FDA publicó el retiro D-517-2015 el 29 de abril de 2015. Peligro reportado: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit